[1] 罗静, 张进生, 王翠芝, 等.经尿道电切术治疗的膀胱尿路上皮肿瘤病理特点及与预后相关性研究[J].首都医科大学学报, 2012, 33(5):656-660.[2] Tang T, Xue H, Cui S, et al. Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese[J]. Fam Cancer, 2014[Epub ahead of print].[3] Verim L, Timirci-Kahraman O, Akbulut H, et al. Funmctional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a turkish population[J]. In Vivo, 2014, 28(3):397-402.[4] Mandal R K, Dubey S, Panda A K, et al. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis[J]. Tumour Biol, 2014.[5] Daniely M, Rona R, Kaplan T, et al. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology[J]. Cancer, 2007, 111(6):517-524.[6] Bergman J, Reznichek R C, Rajfer J. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings[J]. BJU Int, 2008, 101(1):26-29.[7] Dodurga Y, Avci C B, Yilmaz S, et al. UroVysion fluorescence in situ hybridization(UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study[J]. Contemp Oncol(Pozn), 2013, 17(2):156-160.[8] Ke Z, Lai Y, Ma X, et al. Diagnosis of bladder cancer from the voided urine specimens using multitarget fluorescence in situ hybridization[J]. Oncol Lett, 2014, 7(2):325-330.[9] Karaoglu I, van der Heijden A G, Witjes J A. The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer[J]. World J Urol, 2013,[Epub ahead of print].[10] Vorobtsova I E, Kouzova E D, Kolesnikova I S. Comparative evaluation of the predictive value of UroVysion and AURKA FISH tests of urine sediment cells for the diagnosis of bladder cancer[J]. Vopr Onkol, 2013, 59(4):483-486.[11] 刘跃新, 刘小超, 康雯婷, 等.荧光原位杂交技术在膀胱癌检测中的临床应用研究[J].北京医学, 2013, 35(1):1-3.[12] Yoder B J, Skacel M, Hedgepeth R, et al. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings[J]. Am J Clin Pathol, 2007, 127(2):295-301. |